Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 52.30
-1.20 (-2.24%)
At close: Nov 3, 2025
Navana Pharmaceuticals Revenue
Navana Pharmaceuticals had revenue of 2.24B BDT in the quarter ending March 31, 2025, with 28.13% growth. This brings the company's revenue in the last twelve months to 8.47B, up 30.23% year-over-year. In the fiscal year ending June 30, 2024, Navana Pharmaceuticals had annual revenue of 6.90B with 20.89% growth.
Revenue (ttm)
8.47B
Revenue Growth
+30.23%
P/S Ratio
0.66
Revenue / Employee
1.92M
Employees
4,408
Market Cap
5.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 6.90B | 1.19B | 20.89% |
| Jun 30, 2023 | 5.71B | 947.45M | 19.91% |
| Jun 30, 2022 | 4.76B | 1.15B | 31.95% |
| Jun 30, 2021 | 3.61B | 457.57M | 14.53% |
| Jun 30, 2020 | 3.15B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grameenphone | 156.83B |
| Robi Axiata PLC. | 97.63B |
| British American Tobacco Bangladesh Company | 91.37B |
| Square Pharmaceuticals PLC. | 75.86B |
| BRAC Bank PLC. | 74.45B |
| Walton Hi-Tech Industries | 70.82B |
| United Power Generation & Distribution Company | 39.18B |
| Berger Paints Bangladesh | 28.63B |